Utility of B-13 progenitor-derived hepatocytes in hepatotoxicity and genotoxicity studies.

Abstract

AR42J-B-13 (B-13) cells form hepatocyte-like (B-13/H) cells in response to glucocorticoid treatment. To establish its utility in toxicity and genotoxicity screening, cytochrome P450 (CYP) induction, susceptibility to toxins, and transporter gene expression were examined. Conversion to B-13/H cells resulted in expression of male-specific CYP2C11 and sensitivity to methapyrilene. B-13/H cells constitutively expressed CYP1A, induced expression in response to an aryl hydrocarbon receptor agonist, and activated benzo[α]pyrene to a DNA-damaging species. Functional CYP1A2 was not expressed due to deletions in the Cyp1a2 gene. A B-13 cell line stably expressing the human CYP1A2 was therefore engineered (B-13(-TR/h1A2)) and the derived B-13/H cells expressed metabolically functional CYP1A2. Treatment with the cooked food mutagen 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine resulted in a dose-dependent increase in DNA damage. B-13/H cells expressed constitutive androstane receptor (CAR) and induced CYP2B1 mRNA levels in response to classical CAR activators. However, translation to functional CYP2B1 protein was low and increased minimally by CAR activator treatment. B-13/H cells expressed high levels of pregnane X-receptor (PXR) and induced CYP3A1 in response to classical PXR activators. CYP3A genes were inducible, functional, and activated aflatoxin B1 to a DNA-damaging species. All 23 major hepatic transporters were induced when B-13 cells were converted to B-13/H cells, although in many cases, levels remained below those present in adult rat liver. However, bile salt export pump, Abcb1b, multidrug resistance-associated protein, and breast cancer resistance protein transporters were functional in B-13/H cells. These data demonstrate that the B-13 cell generates hepatocyte-like cells with functional drug metabolism and transporter activities, which can alone--or in a humanized form--be used to screen for hepatotoxic and genotoxic endpoints in vitro.

• Authors: Philip M E Probert, Git W Chung, Simon J Cockell, Loranne Agius, Pasquale Mosesso, Steven A White, Fiona Oakley, Colin D A Brown, Matthew C Wright
• Journal: Toxicological sciences : an official journal of the Society of Toxicology (Toxicol Sci) Vol. 137 Issue 2 Pg. 350-70 (Feb 2014) ISSN: 1096-0929 [Electronic] United States
• PMID: 24235770 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Mutagens
• Dexamethasone
• Cytochrome P-450 Enzyme System

Topics

• Animal Testing Alternatives
• Animals
• Cell Culture Techniques
• Cell Differentiation (drug effects)
• Cell Line
• Cell Proliferation (drug effects)
• Cytochrome P-450 Enzyme System (biosynthesis, genetics)
• DNA Damage
• Dexamethasone (pharmacology)
• Embryonic Stem Cells (cytology, drug effects, enzymology)
• Enzyme Induction
• Hepatocytes (cytology, drug effects, enzymology)
• Liver (drug effects, enzymology, pathology)
• Male
• Mutagenicity Tests (methods)
• Mutagens (toxicity)
• Rats
• Sex Characteristics
• Toxicity Tests (methods)
• Transfection